Roivant Sciences Ltd. (ROIV) Social Stream
ROIVANT SCIENCES LTD (ROIV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ROIV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-16 | 6 | $15 | $10 | $12.2 | $9.09 | 34.21% |
| 2021-12-22 | 6 | $16 | $11 | $13.4 | $9.09 | 47.41% |
| 2022-02-15 | 6 | $16 | $11 | $14 | $9.09 | 54.02% |
| 2022-05-13 | 7 | $16 | $11 | $14.2 | $9.09 | 56.22% |
| 2022-05-22 | 7 | $16 | $3.7 | $12.45 | $9.09 | 36.96% |
| 2022-05-23 | 8 | $16 | $6 | $12.833 | $9.09 | 41.18% |
| 2022-05-26 | 8 | $16 | $6 | $12.714 | $9.09 | 39.87% |
| 2022-08-16 | 8 | $16 | $7 | $12.571 | $9.09 | 38.29% |
| 2022-09-28 | 8 | $15 | $6 | $11 | $9.09 | 21.01% |
| 2022-10-27 | 8 | $15 | $6 | $10.5 | $9.09 | 15.51% |
| 2022-11-02 | 7 | $15 | $7 | $10.75 | $9.09 | 18.26% |
| 2022-11-15 | 8 | $15 | $7 | $10.75 | $9.09 | 18.26% |
| 2022-12-12 | 9 | $19 | $8 | $12 | $9.09 | 32.01% |
| 2022-12-19 | 9 | $19 | $8 | $12.25 | $9.09 | 34.76% |
| 2022-12-27 | 9 | $19 | $9 | $12.75 | $9.09 | 40.26% |
| 2023-01-05 | 9 | $19 | $9 | $13.125 | $9.09 | 44.39% |
| 2023-02-14 | 9 | $19 | $10 | $13.25 | $9.09 | 45.76% |
| 2023-03-16 | 9 | $19 | $10 | $13.375 | $9.09 | 47.14% |
| 2023-03-17 | 9 | $19 | $10 | $13.5 | $9.09 | 48.51% |
| 2023-05-18 | 8 | $19 | $10 | $13.875 | $9.09 | 52.64% |
The Trend in the Analyst Price Target
ROIV's average price target has moved up $2.88 over the prior 33 weeks.
Over the past 45 weeks, ROIV's average upside potential has been 97.03%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-02 | 7 | 15 | 7 | 10.750 | 5.11 | 110.37% |
| 2022-11-15 | 9 | 15 | 7 | 10.750 | 5.54 | 94.04% |
| 2023-01-05 | 9 | 19 | 9 | 13.125 | 8.14 | 61.24% |
| 2023-03-16 | 9 | 19 | 10 | 13.375 | 8.50 | 57.35% |
| 2023-05-18 | 8 | 19 | 10 | 13.875 | 9.09 | 52.64% |
ROIV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 35 weeks, ROIV's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, ROIVANT SCIENCES LTD's average analyst price target is higher than 416.49% of them.
- To contextualize these metrics, consider that out of all US stocks, ROIVANT SCIENCES LTD's variance in analysts' estimates is lower than -1881.9% of them.
- In terms of how ROIVANT SCIENCES LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 702.43% of that group.
- In terms of how ROIVANT SCIENCES LTD fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 1453.33% of that group.
Stocks similar to ROIVANT SCIENCES LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PRAX, AVIR, and LMDX.
View All Top Stocks by Price Target
Make investment decisions regarding ROIV using the data that counts. Try POWR Ratings for free.